The Week

Nakamoto (NAKA) gained 11.97% this week to close at $9.17, outperforming the S&P 500 by around 12.05 percentage points, with the benchmark dipping 0.08%. The move was not one-way: the stock opened at $8.07 on Monday, dropped to an intraweek low of $7.60 on Tuesday, then recovered through midweek and surged on Friday to a high of $9.27 before closing at $9.17, leaving a noticeable upper wick. Average daily volume came in at around 245.6k shares, 31.07% above the 60-day median. There was no major company news or earnings this week, leaving the move largely sentiment-driven.

Analyst Ratings

Three brokers cover Nakamoto: two rate it buy and one rates it strong buy, with no hold, under or sell ratings. The consensus rating is strong buy, and the consensus target price sits at $12.67, about 38.13% above the latest close of $9.17. Target prices range from $10.00 to $17.00, indicating wide disagreement. Nakamoto ranks 38th out of 53 names in its healthcare services industry.

The Week Ahead

The macro calendar dominates next week: the Richmond Fed composite index on Tuesday (22 Sep), weekly crude and Cushing inventories on Wednesday (23 Sep), and on Thursday (24 Sep) initial jobless claims, the current account balance, new home sales and natural gas storage. Nakamoto has no earnings scheduled, so macro liquidity and risk appetite will likely steer the stock’s next move.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.